Rapid, simple and high yield production of recombinant proteins in mammalian cells using a versatile episomal system. 2010

Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
NovImmune S.A., 14 Chemin des Aulx, 1228 Plan-Les-Ouates, Switzerland. gmagistrelli@novimmune.com

Many research projects in life sciences require purified biologically active recombinant protein. In addition, different formats of a given protein may be needed at different steps of experimental studies. Thus, the number of protein variants to be expressed and purified in short periods of time can expand very quickly. We have therefore developed a rapid and flexible expression system based on described episomal vector replication to generate semi-stable cell pools that secrete recombinant proteins. We cultured these pools in serum-containing medium to avoid time-consuming adaptation of cells to serum-free conditions, maintain cell viability and reuse the cultures for multiple rounds of protein production. As such, an efficient single step affinity process to purify recombinant proteins from serum-containing medium was optimized. Furthermore, a series of multi-cistronic vectors were designed to enable simultaneous expression of proteins and their biotinylation in vivo as well as fast selection of protein-expressing cell pools. Combining these improved procedures and innovative steps, exemplified with seven cytokines and cytokine receptors, we were able to produce biologically active recombinant endotoxin free protein at the milligram scale in 4-6weeks from molecular cloning to protein purification.

UI MeSH Term Description Entries
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001710 Biotin A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Vitamin H,Biodermatin,Biokur,Biotin Gelfert,Biotin Hermes,Biotin-Ratiopharm,Biotine Roche,Deacura,Gabunat,Medebiotin,Medobiotin,Rombellin,Biotin Ratiopharm,Gelfert, Biotin,Hermes, Biotin,Roche, Biotine
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine

Related Publications

Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
January 2003, Biotechnology progress,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
January 2021, Methods in molecular biology (Clifton, N.J.),
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
October 2004, Biotechnology and applied biochemistry,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
May 2001, Current protocols in protein science,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
July 2008, Biotechnology and bioengineering,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
February 2014, Applied microbiology and biotechnology,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
January 2022, Frontiers in bioengineering and biotechnology,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
August 2009, PloS one,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
September 2005, Biotechnology and bioengineering,
Giovanni Magistrelli, and Pauline Malinge, and Rami Lissilaa, and Séverine Fagète, and Florence Guilhot, and Valéry Moine, and Vanessa Buatois, and Yves Delneste, and Stephan Kellenberger, and Franck Gueneau, and Ulla Ravn, and Marie Kosco-Vilbois, and Nicolas Fischer
March 2024, Antibodies (Basel, Switzerland),
Copied contents to your clipboard!